GEHC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
GEHC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GE HealthCare Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1,116 Mil. GE HealthCare Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $8,747 Mil. GE HealthCare Technologies's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $7,133 Mil. GE HealthCare Technologies's debt to equity for the quarter that ended in Dec. 2023 was 1.38.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for GE HealthCare Technologies's Debt-to-Equity or its related term are showing as below:
During the past 5 years, the highest Debt-to-Equity Ratio of GE HealthCare Technologies was 1.38. The lowest was 0.03. And the median was 0.48.
The historical data trend for GE HealthCare Technologies's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GE HealthCare Technologies Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Debt-to-Equity | N/A | 0.03 | 0.03 | 0.92 | 1.38 |
GE HealthCare Technologies Quarterly Data | ||||||||||||
Dec19 | Dec20 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Debt-to-Equity | Get a 7-Day Free Trial | 0.92 | 1.53 | 1.44 | 1.44 | 1.38 |
For the Health Information Services subindustry, GE HealthCare Technologies's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, GE HealthCare Technologies's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where GE HealthCare Technologies's Debt-to-Equity falls into.
Debt to Equity measures the financial leverage a company has.
GE HealthCare Technologies's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as
Debt to Equity | = | Total Debt | / | Total Stockholders Equity | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Total Stockholders Equity | |
= | (1116 | + | 8747) | / | 7133 | |
= | 1.38 |
GE HealthCare Technologies's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as
Debt to Equity | = | Total Debt | / | Total Stockholders Equity | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Total Stockholders Equity | |
= | (1116 | + | 8747) | / | 7133 | |
= | 1.38 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GE HealthCare Technologies (NAS:GEHC) Debt-to-Equity Explanation
In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.
Be Aware
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Thank you for viewing the detailed overview of GE HealthCare Technologies's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
Kevin Michael O'neill | officer: CEO, PDx | 500 W. MONROE STREET, CHICAGO IL 60661 |
Roland Rott | officer: CEO, Ultrasound | 500 W. MONROE STREET, CHICAGO IL 60661 |
James Saccaro | officer: Chief Financial Officer | ONE BAXTER PARKWAY, DEERFIELD IL 60015 |
Jan Makela | officer: CEO, Imaging | 500 W. MONROE STREET, CHICAGO IL 60661 |
Taha Kass-hout | officer: Chief Technology Officer | 500 W. MONROE STREET, CHICAGO IL 60661 |
Kenneth R. Stacherski | officer: Ch. Supply Chain & Serv. Ofc. | 500 W MONROE, CHICAGO IL 60661 |
Culp H Lawrence Jr | director | GENERAL ELECTRIC COMPANY, ONE FINANCIAL CENTER, SUITE 3700, BOSTON MA 02111 |
William J Stromberg | director | 100 E. PRATT STREET, BALTIMORE MD 21202 |
Thomas J. Westrick | officer: CEO, Patient Care Solutions | 500 W. MONROE STREET, CHICAGO IL 60661 |
Yang Watkin Phoebe L. | director | C/O DOXIMITY, INC., 500 THIRD STREET, SAN FRANCISCO CA 94107 |
Rodney F Hochman | director | 21919 30TH DR SE, BOTHELL WA 98021 |
Tomislav Mihaljevic | director | ONE FINANCIAL CENTER, SUITE 3700, BOSTON MA 02111 |
Lloyd Jr Howell | director | 8283 GREENSBORO DRIVE, MCLEAN VA 22102 |
Anne T Madden | director | C/O HONEYWELL 300 S. TRYON STREET, CHARLOTTE NC 28202 |
Frank R Jimenez | officer: GC & Corporate Secretary | GE HEALTHCARE TECHNOLOGIES INC., 500 W. MONROE ST., CHICAGO IL 606061 |
From GuruFocus
By Business Wire • 12-08-2023
By Business Wire • 12-04-2023
By GuruFocus Research • 01-23-2024
By Business Wire • 01-08-2024
By Business Wire • 11-26-2023
By Business Wire • 10-19-2023
By Business Wire • 10-17-2023
By GuruFocus Research • 11-02-2023
By Business Wire • 01-18-2024
By GuruFocus Research • 01-23-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.